We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
-1.04%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.3B
AUM Growth
+$50.2M
Cap. Flow
-$180M
Cap. Flow %
-4.19%
Top 10 Hldgs %
8.21%
Holding
2,738
New
923
Increased
478
Reduced
355
Closed
498

Sector Composition

Rank Sector Weight
1 Financials 13.47%
2 Healthcare 7.77%
3 Technology 7.7%
4 Consumer Discretionary 4.85%
5 Energy 4.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YUMC icon
1401
Yum China
YUMC
$16.3B
$392K 0.01%
9,447
-9,543
-50% -$450K
AMLX icon
1402
CALL
Amylyx Pharmaceuticals
AMLX
$2.54B
$391K 0.01%
+30,400
New +$687K
EW icon
1403
Edwards Lifesciences
EW
$51.7B
$391K 0.01%
+3,323
New +$373K
EQD.WS
1404
DELISTED
Equity Distribution Acquisition Corp. Warrants, each whole warrant exercisable for one share of Clas
EQD.WS
$390K 0.01%
39,405
MS icon
1405
Morgan Stanley
MS
$340B
$389K 0.01%
+4,449
New +$429K
CMRX
1406
DELISTED
Chimerix, Inc.
CMRX
$389K 0.01%
84,954
CCI icon
1407
PUT
Crown Castle
CCI
$32.2B
$388K 0.01%
+2,100
New +$374K
FOXA icon
1408
Fox Class A
FOXA
$26.9B
$388K 0.01%
9,843
+2,668
+37% +$108K
SSAAU
1409
DELISTED
Science Strategic Acquisition Corp. Alpha Unit
SSAAU
$388K 0.01%
39,352
+1,845
+5% +$18.2K
BBDC icon
1410
Barings BDC
BBDC
$965M
$386K 0.01%
37,325
PTGX icon
1411
CALL
Protagonist Therapeutics
PTGX
$9.44B
$386K 0.01%
16,300
+3,100
+23% +$87.3K
DEN
1412
DELISTED
Denbury Inc.
DEN
$386K 0.01%
+4,914
New +$363K
CB icon
1413
PUT
Chubb
CB
$135B
$385K 0.01%
+1,800
New +$366K
PG icon
1414
Procter & Gamble
PG
$339B
$385K 0.01%
+2,521
New +$394K
AGRIW
1415
DELISTED
AgriFORCE Growing Systems Ltd Warrant
AGRIW
$385K 0.01%
+125,000
New +$68.6K
AA icon
1416
Alcoa
AA
$13.2B
$384K 0.01%
+4,263
New +$310K
SO icon
1417
Southern Company
SO
$107B
$384K 0.01%
+5,289
New +$358K
VFL
1418
DELISTED
abrdn National Municipal Income Fund
VFL
$383K 0.01%
+30,307
New +$399K
TGT icon
1419
CALL
Target
TGT
$68B
$382K 0.01%
+1,800
New +$389K
CME icon
1420
PUT
CME Group
CME
$94.8B
$381K 0.01%
+1,600
New +$376K
MU icon
1421
Micron Technology
MU
$991B
$381K 0.01%
4,897
-58,552
-92% -$4.99M
CTAQW
1422
DELISTED
Carney Technology Acquisition Corp. II Warrant
CTAQW
$381K 0.01%
+38,817
New +$19.3K
SD icon
1423
SandRidge Energy
SD
$503M
$380K 0.01%
23,732
+12,693
+115% +$164K
SMMT icon
1424
Summit Therapeutics
SMMT
$11.1B
$380K 0.01%
+154,950
New +$391K
ONON icon
1425
On Holding
ONON
$12.5B
$379K 0.01%
+15,000
New +$400K

Similar funds

Boothbay Fund Management's Q1 2022 Portfolio in Review

As of Q1 2022, Boothbay Fund Management held 2,738 positions worth $4.3B, up 1.2% from $4.25B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Boothbay Fund Management withdrew a net $180M in Q1 2022, closing 498 positions and reducing 355 holdings. Its most notable exit was Xilinx Inc, an estimated $32.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boothbay Fund Management opened a new position in AXIOS Sustainable Growth Acquisition Corporation worth $11M.

  • Boothbay Fund Management's largest Q1 2022 buy was AXIOS Sustainable Growth Acquisition Corporation: 1,100,000 shares worth $11M.
  • Boothbay Fund Management added most to iShares MBS ETF in Q1 2022, an estimated $20.1M increase.
  • Boothbay Fund Management's biggest Q1 2022 reduction was Amazon, cutting an estimated $103M.
  • Boothbay Fund Management fully exited Xilinx Inc in Q1 2022, selling an estimated $32.9M.
  • Boothbay Fund Management's ten largest holdings make up 8.2% of its $4.3B portfolio in Q1 2022.
  • Boothbay Fund Management opened 923 new positions and closed 498 in Q1 2022.
  • Boothbay Fund Management's portfolio value rose 1.2% quarter-over-quarter to $4.3B.

Based on Boothbay Fund Management's 13F filing for Q1 2022, filed 16 May 2022.